Literature DB >> 15133123

The cytokine receptor gp130 and its soluble form are under hormonal control in human endometrium and decidua.

I Classen-Linke1, G Müller-Newen, P C Heinrich, H M Beier, U von Rango.   

Abstract

The transmembrane protein gp130 plays a central role in cytokine action as a signal transducing receptor subunit common to all interleukin-6 type cytokines. Endometrial tissue obtained from women with a normal menstrual cycle and decidua obtained from women in the first or second trimester of pregnancy were assessed for gp130 by western blotting, immunohistochemistry and enzyme-linked immunosorbent assay (ELISA) analysis. By immunoblotting, two forms of gp130 were detected: one-the soluble form-of approximately 100 kDa and a larger membrane-bound form of approximately 150 kDa. The latter became clearly visible in the mid to late secretory phase and was more pronounced in decidual tissue of second trimester compared to first trimester. Immunohistochemically, gp130 was located in glandular epithelial cells during the mid to late secretory phase, whereas staining in the proliferative phase was rather weak. In first and second trimester decidua, glandular cells were also positively stained. In addition, the invading trophoblast cells were gp130 positive. Soluble gp130 release was measured in the supernatants from primary endometrial and decidual cell cultures by ELISA and reached maximum values in cell cultures without addition of hormones. In cultured endometrial epithelial cells obtained during the proliferative phase of the cycle, the soluble gp130 release increased significantly under combined estradiol/progesterone supplementation which mimics the secretory phase conditions compared to estradiol supplementation alone. In cultured epithelial cells derived from decidual tissue of first trimester of pregnancy, similar effects of hormonal regulation were observed. Our results suggest that the balance between soluble gp130 and its membrane-bound form may play an important role in regulating cytokine action necessary for blastocyst implantation and for further interaction between the decidualized endometrium and the invading trophoblast.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133123     DOI: 10.1093/molehr/gah069

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  3 in total

1.  Blocking Endogenous Leukemia Inhibitory Factor During Placental Development in Mice Leads to Abnormal Placentation and Pregnancy Loss.

Authors:  Amy Winship; Jeanne Correia; Tara Krishnan; Ellen Menkhorst; Carly Cuman; Jian-Guo Zhang; Nicos A Nicola; Evdokia Dimitriadis
Journal:  Sci Rep       Date:  2015-08-14       Impact factor: 4.379

2.  Leukemia Inhibitory Factor (LIF) Inhibition during Mid-Gestation Impairs Trophoblast Invasion and Spiral Artery Remodelling during Pregnancy in Mice.

Authors:  Amy Winship; Jeanne Correia; Jian-Guo Zhang; Nicos A Nicola; Evdokia Dimitriadis
Journal:  PLoS One       Date:  2015-10-19       Impact factor: 3.240

3.  Prokineticin-1 (PROK1) modulates interleukin (IL)-11 expression via prokineticin receptor 1 (PROKR1) and the calcineurin/NFAT signalling pathway.

Authors:  Ian H Cook; Jemma Evans; David Maldonado-Pérez; Hilary O Critchley; Kurt J Sales; Henry N Jabbour
Journal:  Mol Hum Reprod       Date:  2009-10-03       Impact factor: 4.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.